Is Biopsy Gleason Score Independently Associated With Biochemical Progression Following Radical Prostatectomy After Adjusting for Pathological Gleason Score?

Journal of Urology

Volumn 176, Issue 6, 2006, Pages 2453-2458

  Fitzsimons, Nicholas J ^a   Presti Jr , Joseph C ^c   Kane, Christopher J ^d   Terris, Martha K ^e   Aronson, William J ^e   Amling, Christopher L ^f,g   Freedland, Stephen J ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^g Alabama   (United States)

Author keywords

biopsy; disease progression; prostate; prostatectomy; prostatic neoplasms

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BIOPSY; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; LOG RANK TEST; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SEMINAL VESICLE; TIME SERIES ANALYSIS;

AGED; DISEASE PROGRESSION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOMOGRAMS; POSTOPERATIVE PERIOD; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 33751070801     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.014     Document Type: Article

References (20)

1. Partin A.W., Mangold L.A., Lamm D.M., Walsh P.C., Epstein J.I., and Pearson J.D. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843
2. Diblasio C.J., and Kattan M.W. Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 62 suppl (2003) 9
3. D'Amico A.V., Cote K., Loffredo M., Renshaw A.A., and Chen M.H. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 169 (2003) 1320
4. Valicenti R., Lu J., Pilepich M., Asbell S., and Grignon D. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 18 (2000) 2740
5. Albertsen P.C., Hanley J.A., and Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (2005) 2095
6. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499
7. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., and Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591
8. Freedland S.J., Humphreys E.B., Mangold L.A., Eisenberger M., Dorey F.J., Walsh P.C., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433
9. Freedland S.J., Amling C.L., Dorey F., Kane C.J., Presti J.C., Terris M.K., et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 60 (2002) 670
10. King C.R., McNeal J.E., Gill H., and Presti Jr. J.C. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 59 (2004) 386
11. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother Rep 50 (1966) 125
12. Bostwick D.G. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 18 (1994) 796
13. Steinberg D.M., Sauvageot J., Piantadosi S., and Epstein J.I. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21 (1997) 566
14. Roberts W.W., Bergstralh E.J., Blute M.L., Slezak J.M., Carducci M., Han M., et al. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 57 (2001) 1033
15. Moul J.W., Connelly R.R., Lubeck D.P., Bauer J.J., Sun L., Flanders S.C., et al. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol 166 (2001) 1322
16. Stamey T.A., Yemoto C.M., McNeal J.E., Sigal B.M., and Johnstone I.M. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 163 (2000) 1155
17. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D., Sanders M.M., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 (2005) 1248
18. Hall G.S., Kramer C.E., and Epstein J.I. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 16 (1992) 315
19. Pan C.C., Potter S.R., Partin A.W., and Epstein J.I. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol 24 (2000) 563
20. D'Amico A.V., Moul J.W., Carroll P.R., Sun L., Lubeck D., and Chen M.H. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 95 (2003) 1376